Unfractionated IV heparin has been used traditionally for the treatment of hospitalized patients who have a newly diagnosed proximal lower extremity deep venous thrombosis (DVT). However, subcutaneously administered low-molecular-weight heparin (LMWH) has been demonstrated to be as safe and effective as therapy with continuous IV unfractionated heparin. The advantages of LMWH over unfractionated heparin include […]